BackgroundCheck.run
Search For

Eugene P Hickey Deceased208 Dewey St, Toms River, NJ 08753

Eugene Hickey Phones & Addresses

208 Dewey St, Toms River, NJ 08753    732-3497356   

Denver, CO   

Littleton, CO   

Mentions for Eugene P Hickey

Eugene Hickey resumes & CV records

Resumes

Eugene Hickey Photo 17

Eugene Hickey

Eugene Hickey Photo 18

Eugene Hickey

Eugene Hickey Photo 19

Eugene Hickey

Location:
United States
Eugene Hickey Photo 20

Eugene Hickey

Location:
United States

Publications & IP owners

Us Patents

Allosteric Chromenone Inhibitors Of Phosphoinositide 3-Kinase (Pi3K) For The Treatment Of Disease

US Patent:
2022037, Nov 24, 2022
Filed:
Apr 2, 2021
Appl. No.:
17/221209
Inventors:
- New York NY, US
Sean Douglas ARONOW - Boulder CO, US
Nicholas A. BOYLES - Hillsboro OR, US
Markus K. DAHLGREN - Shelton CT, US
Shulu FENG - Ridgewood NJ, US
Eugene R. HICKEY - Danbury CT, US
Thomas Combs IRVIN - Erie CO, US
Edward A. KESICKI - New York NY, US
Jennifer Lynn KNIGHT - Jersey City NJ, US
Gabrielle R. KOLAKOWSKI - Longmont CO, US
Manoj KUMAR - Longmont CO, US
Katelyn Frances LONG - Lafayette CO, US
Christopher Glenn MAYNE - Boulder CO, US
David L. MCELLIGOTT - Bothell WA, US
Johnathan Alexander MCLEAN - Indianapolis IN, US
Loredana PUCA - New York NY, US
Kannan Karukurichi RAVI - Fords NJ, US
Daniel Lee SEVERANCE - San Diego CA, US
Michael Brian WELCH - Westminister CO, US
Tien WIDJAJA - Lafayette CO, US
International Classification:
C07D 405/04
C07D 405/14
C07D 491/056
Abstract:
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I):or a prodrug, solvate, enantiomer, stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, R, R, R, W, X, Y, s, and Ring A are as described herein.

Allosteric Chromenone Inhibitors Of Phosphoinositide 3-Kinase (Pi3K) For The Treatment Of Disease

US Patent:
2023009, Mar 30, 2023
Filed:
May 26, 2022
Appl. No.:
17/825680
Inventors:
- New York NY, US
Sean Douglas ARONOW - Boulder CO, US
Nicholas A. BOYLES - Hillsboro OR, US
Xiaohong CHEN - Broomfield CO, US
Surendra DAWADI - Longmont CO, US
Eugene R. HICKEY - Danbury CT, US
Thomas Combs IRVIN - Erie CO, US
Edward A. KESICKI - New York NY, US
Gabrielle R. KOLAKOWSKI - Durango CO, US
Jennifer Lynn KNIGHT - Jersey City NJ, US
Manoj KUMAR - Broomfield CO, US
Katelyn Frances LONG - Lafayette CO, US
Christopher Glenn MAYNE - Boulder CO, US
Johnathan Alexander MCLEAN - Boulder CO, US
Gerit Maria POTOTSCHNIG - San Diego CA, US
Hua-Yu WANG - Chula Vista CA, US
Michael Brian WELCH - Westminster CO, US
Tien WIDJAJA - Lafayette CO, US
International Classification:
C07D 405/04
C07D 471/04
C07D 487/04
C07D 491/048
C07D 413/04
C07D 407/04
C07D 405/14
C07D 417/04
C07D 513/04
C07D 417/14
C07D 491/052
C07D 495/04
C07D 498/04
Abstract:
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I):or pharmaceutically acceptable salts thereof wherein R, R, R, R, R, R, R, R, and R, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof.

Allosteric Chromenone Inhibitors Of Phosphoinositide 3-Kinase (Pi3K) For The Treatment Of Disease

US Patent:
2023001, Jan 19, 2023
Filed:
May 2, 2022
Appl. No.:
17/734745
Inventors:
- New York NY, US
Sean Douglas ARONOW - Boulder CO, US
Nicholas A. BOYLES - Hillsboro OR, US
Xiaohong CHEN - Broomfield CO, US
Surendra DAWADI - Longmont CA, US
Eugene R. HICKEY - Danbury CT, US
Thomas Combs IRVIN - Erie CO, US
Edward A. KESICKI - New York NY, US
Gabrielle R. KOLAKOWSKI - Durango CO, US
Jennifer Lynn KNIGHT - Jersey City NJ, US
Manoj KUMAR - Broomfield CO, US
Katelyn Frances LONG - Lafayette CO, US
Christopher Glenn MAYNE - Boulder CO, US
Alfredo PICADO - Superior CO, US
Gerit Maria POTOTSCHNIG - San Diego CA, US
Hua-Yu WANG - Chula Vista CA, US
Michael Brian WELCH - Westminster CO, US
Tien WIDJAJA - Lafayette CO, US
Nathan Edward WRIGHT - San Diego CA, US
International Classification:
C07D 405/04
C07D 405/14
C07D 417/04
Abstract:
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated withor pharmaceutically acceptable salts thereof wherein R, R, R, R, R, R, R, R, and R, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof.

Allosteric Chromenone Inhibitors Of Phosphoinositide 3-Kinase (Pi3K) For The Treatment Of Disease

US Patent:
2023001, Jan 19, 2023
Filed:
May 2, 2022
Appl. No.:
17/734705
Inventors:
- New York NY, US
Sean Douglas ARONOW - Boulder CO, US
Nicholas A. Boyles - Hillsboro OR, US
Surendra DAWADI - Longmont CO, US
Eugene R. HICKEY - Danbury CT, US
Thomas Combs IRVIN - Erie CO, US
Edward A. KESICKI - New York NY, US
Gabrielle R. KOLAKOWSKI - Durango CO, US
Jennifer Lynn KNIGHT - Jersey City NJ, US
Manoj KUMAR - Broomfield CO, US
Katelyn Frances LONG - Lafayette CO, US
Christopher Glenn MAYNE - Boulder CO, US
Alfredo PICADO - Superior CO, US
Gerit Maria POTOTSCHNIG - San Diego CA, US
Michael Brian WELCH - Westminster CO, US
Tien WIDJAJA - Lafayette CO, US
Xiaohong CHEN - Broomfield CO, US
Nathan Edward WRIGHT - San Diego CA, US
Hua-Yu WANG - Chula Vista CA, US
International Classification:
C07D 405/10
C07D 311/30
C07D 417/12
C07D 405/12
C07D 413/10
C07D 407/04
A61P 35/00
Abstract:
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I):or pharmaceutically acceptable salts thereof wherein R, R, R, R, R, R, R, R, and R, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.